Simultaneous determination of six HIV nucleoside analogue reverse transcriptase inhibitors and nevirapine by liquid chromatography with ultraviolet absorbance detection.
about
Interindividual variability in pharmacokinetics of generic nucleoside reverse transcriptase inhibitors in TB/HIV-coinfected Ghanaian patients: UGT2B7*1c is associated with faster zidovudine clearance and glucuronidationAIDS diarrhea and antiretroviral drug concentrations: a matched-pair cohort study in Port au Prince, Haiti.CYP2B6 variants and plasma efavirenz concentrations during antiretroviral therapy in Port-au-Prince, HaitiTransmitted antiretroviral drug resistance among acute and recent HIV infections in North Carolina from 1998 to 2007Measurement of antiretroviral drugs in the lungs of HIV-infected patients.Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxisPharmacokinetics of generic and trade formulations of lamivudine, stavudine and nevirapine in HIV-infected Malawian childrenStudies on antiretroviral drug concentrations in breast milk: validation of a liquid chromatography-tandem mass spectrometric method for the determination of 7 anti-human immunodeficiency virus medicationsAddition of 7 days of zidovudine plus lamivudine to peripartum single-dose nevirapine effectively reduces nevirapine resistance postpartum in HIV-infected mothers in Malawi.Combined oral contraceptives and antiretroviral PK/PD in Malawian women: pharmacokinetics and pharmacodynamics of a combined oral contraceptive and a generic combined formulation antiretroviral in MalawiAn accurate and precise high-performance liquid chromatography method for the rapid quantification of the novel HIV integrase inhibitor raltegravir in human blood plasma after solid phase extractionExploration of CYP450 and drug transporter genotypes and correlations with nevirapine exposure in MalawiansPoly(lactic-co-glycolic) Acid-Chitosan Dual Loaded Nanoparticles for Antiretroviral Nanoformulations.Artemether-Lumefantrine Exposure in HIV-Infected Nigerian Subjects on Nevirapine-Containing Antiretroviral TherapyEfficacy and safety of switching from nevirapine immediate-release twice daily to nevirapine extended-release once daily in virologically suppressed HIV-infected patients: a retrospective cohort study in Taiwan.Pharmacokinetic modelling of efavirenz, atazanavir, lamivudine and tenofovir in the female genital tract of HIV-infected pre-menopausal women.Interactions between buprenorphine and antiretrovirals: nucleos(t)ide reverse transcriptase inhibitors (NRTI) didanosine, lamivudine, and tenofovir.Lack of clinically significant drug interactions between nevirapine and buprenorphine.Genital tract, cord blood, and amniotic fluid exposures of seven antiretroviral drugs during and after pregnancy in human immunodeficiency virus type 1-infected women.Unreported antiretroviral use by HIV-1-infected participants enrolling in a prospective research study.Stress Degradation Behavior of Abacavir Sulfate and Development of a Suitable Stability-Indicating UHPLC Method for the Determination of Abacavir, its Related Substances, and Degradation Products.Antiretroviral drug concentrations and HIV RNA in the genital tract of HIV-infected women receiving long-term highly active antiretroviral therapy.Development and validation of a normal-phase HPTLC method for the simultaneous analysis of Lamivudine and Zidovudine in fixed-dose combination tablets.Voltammetric Behavior of Indinavir and Determination in Pharmaceutical Dosage FormsAmperometric Immunosensor for the Determination of 2′,3′-dideoxyinosineDetermination of 2′,3′‐Dideoxyinosine Using Iron (II) Phthalocyanine Modified Carbon Paste ElectrodeDevelopment and Validation of a Rapid Liquid Chromatography Tandem Mass Spectrometry Method to Quantify Nevirapine in Human Plasma and its Application to Bioequivalence Study in Healthy Human Subjects
P2860
Q24648578-143686D1-3E61-4FD4-A29D-A04FB7DFF2C1Q30426578-A5D8B404-A7BD-4E61-AE37-F14D944DDBB6Q30438405-AB71CA4C-BF86-458A-92B8-00BE8699AFD1Q33814896-631B4256-C000-499E-AB51-52B99C1A5FC0Q33818018-3AC22650-49D1-4D94-92F4-F6B49B225592Q33821257-AA965BF3-F58F-4F2E-A69D-2D1CF7C38756Q33839338-D1551B30-F552-49CA-BE59-952D9C2A6B14Q33983923-08807629-EB70-47A5-9729-120A6E00BCD5Q34033166-F736F0DC-4ED5-4D79-AE03-BBB3080124CEQ35222849-C9C8B042-0872-44BA-9A47-4A2EEFFD7365Q35781692-E530EDE8-53BF-4713-ABAC-43F8A0DDBB10Q35796733-B9890010-21FF-4CEB-A04F-A31B01D81DE7Q36020685-66F4910D-48DE-4A5F-B1B7-6C7A770FB64EQ36290691-91648D62-3042-4FAF-8DE0-6483EC249102Q36343668-30F6F542-1760-4E51-8A14-E4C1F64CB26AQ36430073-D3781E26-951B-48AF-8B42-610376554B83Q37045335-37C22FC2-19ED-43B9-8D56-7D4142EE8B8CQ37045349-1241973A-0F65-47BC-BC24-B35472E0F928Q37204271-334AE667-F237-45D8-AE4D-5DC0D07451FBQ37503472-36BF968B-3C5F-4D99-8D30-6C10BA05C055Q42425202-8E24517A-725C-46C4-8ED7-C9FAD7987775Q46791174-EC93D139-D906-40E1-B19B-EC1900B7A50CQ49883420-FD68DEB5-3D15-4464-B54E-1F468500994EQ58143938-0C580073-4509-4E67-8C1D-6BDCECADDE6AQ58268289-9C8F150C-CD8D-4234-9F4C-2A977C8D3FAEQ58285714-0724A4C1-3771-47F1-A8F4-1A65B9124542Q58307180-35D4E8EF-08C1-48A3-B8AC-CE468D1358E2
P2860
Simultaneous determination of six HIV nucleoside analogue reverse transcriptase inhibitors and nevirapine by liquid chromatography with ultraviolet absorbance detection.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Simultaneous determination of ...... raviolet absorbance detection.
@en
Simultaneous determination of ...... raviolet absorbance detection.
@nl
type
label
Simultaneous determination of ...... raviolet absorbance detection.
@en
Simultaneous determination of ...... raviolet absorbance detection.
@nl
prefLabel
Simultaneous determination of ...... raviolet absorbance detection.
@en
Simultaneous determination of ...... raviolet absorbance detection.
@nl
P2093
P1476
Simultaneous determination of ...... raviolet absorbance detection.
@en
P2093
Angela D M Kashuba
Naser L Rezk
Richard R Tidwell
P304
P356
10.1016/S1570-0232(03)00224-1
P577
2003-07-01T00:00:00Z